Drugs / NaFeEDTA
NaFeEDTA
Trials 3 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03894449 | Apr → Jul 2019 | iron deficiency anemia | University of Veterinary and Animal Sciences, Lahore - Pakistan | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00386074 | May → Dec 2004 | anemia | Wageningen University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01634945 | Apr 2012 → May 2013 | anemia | Swiss Federal Institute of Technology | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NaFeEDTA | “A combination dosage of prebiotic (Inulin or GOS) and Iron Fortificant (FeSO4 or NaFeEDTA) will be given to the study subjects.” NCT03894449 ↗ |
| Known as | Sodium iron edetic acid | “Sodium iron edetic acid (NaFeEDTA) might be a more bioavailable source of iron than electrolytic iron, when added to maize flour.” PMID 17531887 ↗ May 2007 |
| Known as | sodium iron EDTA | “a complementary food (CF) fortified with sodium iron EDTA (NaFeEDTA) plus either ferrous fumarate (FeFum) or ferric pyrophosphate (FePP)” PMID 28708072 ↗ Jul 2017 |